Evidence map›Paper›PMID 30907211›Full record

GuidelineThe world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry2019

Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBP.

Ana C Andreazza, Isabelle Laksono, Brisa S Fernandes, Catherine Toben, Piotr Lewczuk, Peter Riederer, Sidney H Kennedy, Dimitrios Kapogiannis, Florence Thibaut, Manfred Gerlach and 6 more

Abstract readPractice Guideline
In one paragraph

Guideline in The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Observational
  7. Article
  8. Article
  9. The researcher's guide to selecting biomarkers in mental health studies.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Biomarkers in psychiatric disorders: status quo, impediments and facilitators.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana C Andreazzaa Department of Pharmacology & Toxicology , University of Toronto , Toronto , ON , Canada.ORCID 0000-0002-4323-7273
Isabelle Laksonoa Department of Pharmacology & Toxicology , University of Toronto , Toronto , ON , Canada.
Brisa S Fernandesb Department of Psychiatry, Centre for Addiction and Mental Health , University of Toronto , Toronto , ON , Canada.
Catherine Tobenc Discipline of Psychiatry, Adelaide Medical School , University of Adelaide , Adelaide , SA , Australia.
Piotr Lewczukd Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.ORCID 0000-0002-8101-6535
Peter Riedererf Department of Psychiatry, Psychosomatics and Psychotherapy , University of Wuerzburg, Medical School , Würzburg , Germany.
Sidney H Kennedyh Canadian Biomarker Integration Network for Depression & University Health Network , Toronto , ON , Canada.ORCID 0000-0001-5339-7185
Dimitrios Kapogiannisi Laboratory of Neurosciences , Intramural Research Program, National Institute on Aging, National Institutes of Health (USA) , Baltimore , MD , USA.
Florence Thibautj Faculty of Medicine, INSERM U 894 Centre Psychiatry-Neurosciences, Department of Psychiatry , University Sorbornne-Paris Cite , Paris , France.ORCID 0000-0002-0204-5435
Manfred Gerlachk Centre for Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy , University Hospital of Würzburg , Würzburg , Germany.
Carla Gallol Departamento de Ciencias Celulares y Moleculares/Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía , Universidad Peruana Cayetano Heredia , Lima , Peru.ORCID 0000-0001-8348-0473
Yong-Ku Kimm Department of Psychiatry , Korea University , Seoul , South Korea.
Edna Grünblattn Department of Child and Adolescent Psychiatry and Psychotherapy , University Hospital of Psychiatry Zurich, Zurich, Switzerland.ORCID 0000-0001-8505-7265
Lakshmi Yathamq Department of Psychiatry , University of British Columbia , Vancouver , Canada.
Michael Berkr Deakin University , IMPACT Strategic Research Centre, School of Medicine, Barwon Health , Geelong , VIC , Australia.ORCID 0000-0002-5554-6946
Bernhard T Baunes Department of Psychiatry , Melbourne Medical School, University of Melbourne , Melbourne , VIC , Australia.ORCID 0000-0001-6548-426X

Funding

Studies in Dementia and Neurodegenerative DiseasesZIAAG000975 · NIA · NATIONAL INSTITUTE ON AGING · PI KAPOGIANNIS, DIMITRIOS · 2009 to 2025
$31.5M
Intramural NIH HHS Z99 AG999999
6 · The paper itself

Abstract

Recently, there has been a major shift in the field of psychiatry towards the exploration of complex relationships between blood-based biomarkers and the pathophysiology of psychiatric and neuropsychiatric disorders. However, issues with study reproducibility, validity and reliability have hindered progress towards the identification of clinically relevant biomarkers for psychiatry. The achievement of laboratory validity is a crucial first step for the posterior development of clinical validity. There is evidence that the variability observed in blood-based research studies may be minimised with the implementation of standardised pre-analytical methods and uniform clinical protocols (i.e., pre-venipuncture). It has been documented that errors made in the pre-analytical phase account for 46-68.2% of laboratory testing errors. Thus, standardising clinical assessment, ethical procedures and pre-analytical phase of clinical research is essential for the reproducibility, validity and reliability of blood marker assessment, and reducing the risk of invalid test results. Various other areas of research have already moved towards guidelines for the standardised collection of blood-based biomarkers. Here we aim to provide a set of guidelines that we believe would improve biomarker research: (1) pre-venipuncture information and documentation, (2) ethics of participant consent and (3) pre-analytical methods. Ultimately, we hope this will assist study planning and will improve data comparison across studies allowing for the discovery of biomarkers in psychiatry with both laboratorial and clinical validity.

Indexed as

Advisory CommitteesBiological PsychiatryBiomarkersBlood Specimen CollectionConsensusHumansMental DisordersNeurodegenerative DiseasesReproducibility of ResultsSocieties, MedicalBiomarkersBiomarkersguidelinesreliabilitystandardisationvalidity

Identifiers

PMID30907211
PMCPMC6728424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.